Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pavlidis

Showing results (41-50 of 267) with videos related to

Pageof 27
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Oncology for medical students: a new ESO educational avenueN Pavlidis, J B Vermorken, A Costa
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC)E Felip, N Pavlidis, R A Stahel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancerR Herrmann, L M Jost, N Pavlidis, et al.
The American Journal of Cardiology|January 5, 1999
Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarctionH Ohlin, N Pavlidis, A K Ohlin
Circulation|October 13, 2010
Iatrogenic giant Osborn wavesAntonios N Pavlidis, Antreas Giannakopoulos, Athanasios J Manolis
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2008
Heterogeneity in cancer guidelines: should we eradicate or tolerate?G Pentheroudakis, R Stahel, H Hansen, et al.
Acute Cardiac Care|January 31, 2015
Balloon-assisted tracking during primary percutaneous coronary interventionAntonios N Pavlidis, Grigoris V Karamasis, Paul Rees
Current Pharmaceutical Design|June 20, 2020
PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?Ioannis Felekos, Grigoris V Karamasis, Antonis N Pavlidis
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2011
Fourteen years of evolution of ESMO Guidelines: from the minimum recommendations to the Consensus Conference-derived guidelinesN Pavlidis, R Stahel, H Hansen, et al.
Journal of Chemotherapy (Florence, Italy)|July 19, 2003
Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancerA Bamias, D Papamichael, K Syrigos, et al.
Pageof 27

Showing results (41-50 of 267) with videos related to

Sort By:
Pageof 27
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2005
Oncology for medical students: a new ESO educational avenueN Pavlidis, J B Vermorken, A Costa
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC)E Felip, N Pavlidis, R A Stahel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancerR Herrmann, L M Jost, N Pavlidis, et al.
The American Journal of Cardiology|January 5, 1999
Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarctionH Ohlin, N Pavlidis, A K Ohlin
Circulation|October 13, 2010
Iatrogenic giant Osborn wavesAntonios N Pavlidis, Antreas Giannakopoulos, Athanasios J Manolis
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2008
Heterogeneity in cancer guidelines: should we eradicate or tolerate?G Pentheroudakis, R Stahel, H Hansen, et al.
Acute Cardiac Care|January 31, 2015
Balloon-assisted tracking during primary percutaneous coronary interventionAntonios N Pavlidis, Grigoris V Karamasis, Paul Rees
Current Pharmaceutical Design|June 20, 2020
PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?Ioannis Felekos, Grigoris V Karamasis, Antonis N Pavlidis
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2011
Fourteen years of evolution of ESMO Guidelines: from the minimum recommendations to the Consensus Conference-derived guidelinesN Pavlidis, R Stahel, H Hansen, et al.
Journal of Chemotherapy (Florence, Italy)|July 19, 2003
Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancerA Bamias, D Papamichael, K Syrigos, et al.
Pageof 27